A new predictive tool for the early risk assessment of gestational diabetes mellitus

Primary Care Diabetes

Volumn 10, Issue 5, 2016, Pages 315-323

  Capula, Carmelo ^a   Chiefari, Eusebio ^b   Borelli, Massimo ^c   Oliverio, Rosa ^a   Vero, Anna ^a   Foti, Daniela ^b   Puccio, Luigi ^a   Vero, Raffaella ^a   Brunetti, Antonio ^b  

^a PUGLIESE CIACCIO HOSPITAL   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Fetal complications; Gestational diabetes mellitus; Maternal complications; Screening for GDM

Indexed keywords

ADULT; ADVERSE OUTCOME; APGAR SCORE; ARTICLE; COST EFFECTIVENESS ANALYSIS; DYSTOCIA; EARLY DIAGNOSIS; ECLAMPSIA; FEMALE; FETUS DISTRESS; FRACTURE; GESTATIONAL AGE; HUMAN; HYDRAMNIOS; HYPOCALCEMIA; HYPOGLYCEMIA; INTERMEDIATE RISK PATIENT; LARGE FOR GESTATIONAL AGE; MACROSOMIA; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; NEONATAL HYPERBILIRUBINEMIA; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN DISEASE; NEWBORN INTENSIVE CARE; OLIGOHYDRAMNIOS; ORAL GLUCOSE TOLERANCE TEST; PERINATAL DEATH; POLYCYTHEMIA; PRACTICE GUIDELINE; PREDICTIVE VALUE; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCREENING; SMALL FOR DATE INFANT; TRANSIENT TACHYPNEA OF THE NEWBORN; COST BENEFIT ANALYSIS; ECONOMICS; GLUCOSE TOLERANCE TEST; HEALTH CARE COST; ITALY; MASS SCREENING; PREGNANCY; PREVALENCE; PROCEDURES; PROGNOSIS; RISK FACTOR; STANDARDS;

ADULT; COST-BENEFIT ANALYSIS; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; HEALTH CARE COSTS; HUMANS; ITALY; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84971659659     PISSN: 17519918     EISSN: 18780210     Source Type: Journal    
DOI: 10.1016/j.pcd.2016.05.004     Document Type: Article

References (30)

1. [1] Hunt, K.J., Schuller, K.L., The increasing prevalence of diabetes in pregnancy. Obstet. Gynecol. Clin. North Am. 34 (2007), 173–199.
2. [2] HAPO Study Cooperative Research Group, Metzger, B.E., Lowe, L.P., et al. Hyperglycemia and adverse pregnancy outcomes. N. Engl. J. Med. 358 (2008), 1991–2002.
3. [3] International Association of Diabetes and Pregnancy Study Groups Consensus Panel, International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33 (2010), 676–682.
4. [4] World Health Organisation Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. 2013 Available from http://apps.who.int/iris/bitstream/10665/85975/1/WHO_NMH_MND_13.2_eng.pdf (accessed 20.12.15).
5. [5] American Diabetes Association (ADA), Standards of medical care in Diabetes-2011. Diabetes Care 34 (2011), S11–S61.
6. [6] AACE, American Association of Clinical Endocrinologists medical guidelines for developing a diabetes mellitus comprehensive care plan. Endocrin. Pract. 17 (2011), 1–53.
7. [7] National Institute for Health and Care Excellence (NICE), Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. Clinical guideline NG3 [article online]. 2015 Available from www.nice.org.uk/guidance/ng3/resources/diabetes-in-pregnancy-management-of-diabetes-and-itscomplications-from-preconception-to-the-postnatal-period-51038446021 (accessed 20.12.15).
8. [8] Vandorsten, J.P., Dodson, W.C., Espeland, M.A., et al. NIH consensus development conference: diagnosing gestational diabetes mellitus. NIH Consens. State Sci. Statements 29 (2013), 1–31.
9. [9] Scottish Intercollegiate Guidelines Network, National clinical guideline 116: Management of Diabetes Edinburgh: SIGN [article online]. 2010 Available from www.sign.ac.uk/pdf/sign116.pdf (accessed December 2015).
10. [10] Agarwal, M.M., Gestational diabetes mellitus: an update on the current international diagnostic criteria. World J. Diabetes 6 (2015), 782–791.
11. [11] Capula, C., Chiefari, E., Vero, A., et al. Gestational diabetes mellitus: screening and outcomes in southern Italian pregnant women. ISRN Endocrinol., 2013, 2013, 387495.
12. [12] National Institute for Clinical Excellence, Diabetes in Pregnancy: Full Guideline. Clinical Guideline 63. National Collaborating Centre for Women's and Children's Health. 2008, NICE, London, UK.
13. [13] Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81 (2004), 19–25.
14. [14] R Core Team, R: A Language and Environment for Statistical Computing. 2014, R Foundation for Statistical Computing, Vienna, Austria Accessible to www.R-project.org/.
15. [15] Miailhe, G., Kayem, G., Girard, G., et al. Selective rather than universal screening for gestational diabetes mellitus?. Eur. J. Obstet. Gynecol. Reprod. Biol. 191 (2015), 95–100.
16. [16] Meek, C.L., Lewis, H.B., Patient, C., et al. Diagnosis of gestational diabetes mellitus: falling through the net. Diabetologia 58 (2015), 2003–2012.
17. [17] Trujillo, J., Vigo, A., Duncan, B.B., et al. Impact of the International Association of Diabetes and Pregnancy Study Groups criteria for gestational diabetes. Diabetes Res. Clin. Pract. 108 (2015), 288–295.
18. [18] Torloni, M.R., Betrán, A.P., Horta, B.L., et al. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes. Rev. 10 (2009), 194–203.
19. [19] Di Cianni, G., Volpe, L., Lencioni, C., et al. Prevalence and risk factors for gestational diabetes assessed by universal screening. Diabetes Res. Clin. Pract. 62 (2003), 131–137.
20. [20] Makgoba, M., Savvidou, M.D., Steer, P.J., An analysis of the interrelationship between maternal age, body mass index and racial origin in the development of gestational diabetes mellitus. BJOG 119 (2012), 276–282.
21. [21] Lo, J.C., Feigenbaum, S.L., Escobar, G.J., et al. Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome: a population-based study. Diabetes Care 29 (2006), 1915–1917.
22. [22] Sacks, D.A., Hadden, D.R., Maresh, M., et al. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care 35 (2012), 526–528.
23. [23] Catalano, P.M., McIntyre, H.D., Cruickshank, J.K., et al. Hyperglycemia and adverse pregnancy outcome study. Associations of GDM and obesity with pregnancy outcomes. Diabetes Care 35 (2012), 780–786.
24. [24] HAPO Study Cooperative Research Group, Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study: associations with maternal body mass index. BJOG 117 (2010), 575–584.
25. [25] Lapolla, A., Bonomo, M., Dalfrà, M.G., et al. Prepregnancy BMI influences maternal and fetal outcomes in women with isolated gestational hyperglycaemia: a multicentre study. Diabetes Metab. 36 (2010), 265–270.
26. [26] Capula, C., Chiefari, E., Vero, A., et al. Predictors of postpartum glucose tolerance testing in Italian women with gestational diabetes mellitus. ISRN Endocrinol., 2013, 2013, 182505.
27. [27] Palomba, S., Falbo, A., Russo, T., et al. The risk of a persistent glucose metabolism impairment after gestational diabetes mellitus is increased in patients with polycystic ovary syndrome. Diabetes Care 35 (2012), 861–867.
28. [28] Capula, C., Chiefari, E., Vero, A., et al. Prevalence and predictors of postpartum glucose intolerance in Italian women with gestational diabetes mellitus. Diabetes Res. Clin. Pract. 105 (2014), 223–230.
29. [29] Qin, J.Z., Pang, L.H., Li, M.J., et al. Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis. Reprod. Biol. Endocrinol., 11, 2013, 56.
30. [30] Agarwal, M.M., Dhatt, G.S., Othman, Y., Gestational diabetes mellitus prevalence: effect of the laboratory analytical variation. Diabetes Res. Clin. Pract. 109 (2015), 493–499.